RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
RAB4A |
IPI00549945 |
3.072 |
Evidence |
|
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
3.072 |
Evidence |
|
IL6R |
IL6R: Interleukin-6 receptor alpha chain precursor |
WAS |
WAS, IMD2: Wiskott-Aldrich syndrome protein |
3.072 |
Evidence |
|
MAL2 |
MAL2: Protein MAL2 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
3.072 |
Evidence |
|
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
PTPRR |
PTPRR, ECPTP, PTPRQ: Receptor-type tyrosine-protein phosphatase R precursor |
3.072 |
Evidence |
|
FPR1 |
FPR1: fMet-Leu-Phe receptor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
DNAJC13 |
DNAJC13, KIAA0678, RME8: DnaJ homolog subfamily C member 13 |
KRT8 |
KRT8, CYK8: Keratin, type II cytoskeletal 8 |
3.072 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
RYR2 |
RYR2: Ryanodine receptor 2 |
3.072 |
Evidence |
|
STAT1 |
STAT1: Signal transducer and activator of transcription 1-alpha/beta |
EDNRB |
EDNRB, ETRB: Endothelin B receptor precursor |
3.072 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
AVPR2 |
AVPR2, ADHR, DIR, DIR3, V2R: Vasopressin V2 receptor |
3.072 |
Evidence |
|
F2RL2 |
F2RL2, PAR3: Proteinase-activated receptor 3 precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
CCR5 |
CCR5: CCR5 receptor (Fragment) |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
DUSP3 |
DUSP3, VHR: Dual specificity protein phosphatase 3 |
PTPRE |
PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor |
3.072 |
Evidence |
|
TBXA2R |
TBXA2R: Thromboxane A2 receptor |
BDKRB2 |
BDKRB2, BKR2: B2 bradykinin receptor |
3.072 |
Evidence |
|
FOS |
FOS, G0S7: Proto-oncogene protein c-fos |
PCSK9 |
PCSK9, NARC1, PSEC0052: Proprotein convertase subtilisin/kexin type 9 precursor |
3.072 |
Evidence |
|
HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
GRIA3 |
GRIA3, GLUR3, GLURC: Glutamate receptor 3 precursor |
LCP2 |
LCP2: Lymphocyte cytosolic protein 2 |
3.072 |
Evidence |
|
DRD2 |
DRD2: D(2) dopamine receptor |
OPRD1 |
OPRD1, OPRD: Delta-type opioid receptor |
3.072 |
Evidence |
|
PDPK1 |
PDPK1, PDK1: 3-phosphoinositide-dependent protein kinase 1 |
RYR2 |
RYR2: Ryanodine receptor 2 |
3.072 |
Evidence |
|
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
CASP9 |
CASP9, MCH6: Caspase-9 precursor |
3.072 |
Evidence |
|
IL8RB |
IL8RB, CXCR2: High affinity interleukin-8 receptor B |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
PROC |
PROC: Vitamin K-dependent protein C precursor |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
LTB4R |
LTB4R, BLT, BLT1, BLTR, CMKRL1, GPR16, P2RY7: Leukotriene B4 receptor 1 |
OPRM1 |
OPRM1, MOR1: Mu-type opioid receptor |
3.072 |
Evidence |
|
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
RPS6KA3 |
RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 |
3.072 |
Evidence |
|
FOSL2 |
FOSL2, FRA2: Fos-related antigen 2 |
PCSK9 |
PCSK9, NARC1, PSEC0052: Proprotein convertase subtilisin/kexin type 9 precursor |
3.072 |
Evidence |
|